Systemic Anti-Cancer Therapy Data Set
Captures activity data relating to the treatment of cancer with medicines.
Contents
- Documentation
About this standard
- Publisher
- NHS England
- Also known as
- Also known as SACT.
- Reference code
- DCB1533 Amd 80/2018
- Publication date
- 06/12/2018
- Status
- Active
Show definitions of statuses
Active. Active standards are stable, maintained and have been approved, assured or endorsed for use by qualified bodies.
Deprecated Deprecated standards are available for use and are maintained, but are being phased out, so new functionality will not be added.
Retired standards Retired standards are not being maintained or supported and should not be used.
- Standard type
- Collections
- Information standards
Show definitions of standard types
Collections. A Collection is a systematic gathering of a specified selection of data or information for a particular stated purpose from existing records held within health and care systems and electronic devices.
Extractions. An extraction is a type of collection that is pulled from an operational system by the data controller and transmitted to the receiver without additional processing or transcription by the sender.
Information standards. Information standards are agreed ways of doing something, written down as a set of precise criteria so they can be used as rules, guidelines, or definitions.
Technical Standards and specifications. Technical standards and specifications specify how to make information available technically including how the data is structured and transported.
- Contact point
Using this standard
- Applies to
- Cancer centres
- All providers of NHS commissioned systemic anti-cancer therapy services.
- Impacts on
- Implementation of this information standard impacts all health IT systems suppliers providing systems to the above providers; suppliers should work with their customers to determine necessary changes. All commissioners of NHS funded systemic anti-cancer therapy services should review impact on business processes and enable consequential changes.
- Associated medias
- Conformance date
- 01/12/2019
- Effective from
- 06/12/2018
Topics and care settings
- Topic
- Data definitions and terminologies
- Demographics
- Prescribing
- Reference data
- Care setting
- Hospital
Dependencies and related standards
- Dependencies
No known dependencies.
- Related standards
No known related standards.
Review Information
- Scope
- NHS Services
- Sponsor
Dr Jem Rashbass, Director for National Disease Registration, Public Health England.
- Senior Responsible Officer
Professor John Newton, Chief Knowledge Officer, Public Health England.
- Business Lead
- Andrew Murphy, Head of Cancer Datasets, National Cancer Registration and Analysis Service, Public Health England.
- Approval date
- 22/11/2018
- Post Implementation review Date
- 31/08/2020
Legal basis and endorsements
- Legal authority
Section 250 of the Health and Social Care Act 2012
This information standard is published under section 250 of the Health and Social Care Act 2012
NHS standard contract
This collection is published under the NHS Standard Contract.
More information
This information standard specifies a data set for use at both national and local levels to generate secondary uses information about systemic anti-cancer therapy treatment, covering neoplasms coded within ICD-10 diagnosis codes range C00 - C97, D00 - D48 and E85.9.
Providers of systemic anti-cancer therapy services are required to provide a monthly submission of this data set to Public Health England.
This release introduces:
- new data items
- amendments to existing data items
- deletions of data items
- clearer definitions and expanded formats to improve the quality of submitted data
- the removal of the intention to change to xml submission.
These relate to:
- local patient identifier, patient family and given names
- organisation codes to reflect “ANANA”
- person stated gender code
- diagnoses using SNOMED CT
- adjunctive therapy type
- performance status (adult aged 19 years and older)
- administration measurement per actual dose
- a series of new outcome summaries, measuring
- curative (completed)
- curative (not completed)
- non curative.
In addition, data items have been introduced to enable the conduct of two pilots relating to:
- dictionary of medicines and devices (dm+d)
- regimen outcome summary – toxicity.
Page last updated: 03 May 2024